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Introduction
Engineered nanoparticles (NPs) are frequently used in commercial products due to their unique physical and chemical characteristics, which depend on their specific dimensions (100 nm or less in one or more dimension). 1 Silicon dioxide (silica [SiO 2 ]) nanomaterials are of great importance in the fabrication of electric and thermal insula tors, catalyst supports, and drug carriers, as well as in gene delivery, media for coating processes, and filler materials. 2 They are also produced on an industrial scale as additives for cosmetics, drugs, printer toners, varnishes, and food packing. 3 The same properties that mediate the advantages of nanotechnology also confer their potential toxic effects, resulting in a major health concern regarding the use of nanomaterials. the circulatory and lymphatic systems, causing longlasting cell damage. 10, 11 Several studies show that SiO 2 NPs induce dosedependent cytotoxicity in in vitro systems, including human lung epithelial cells 12 and bronchoalveolar carcino maderived cells 13 and human alveolar barrier, 14 as well as murine macrophages. 15 Shortterm instillations or inhalation exposure to amorphous SiO 2 NPs showed that these particles possess the potential to cause toxic effects in the lung. [16] [17] [18] Immunomodulatory effects by particle exposure during the sensitization phase have also been demonstrated. 19, 20 Recently, surface modifications of SiO 2 NPs were synthe sized to study their influence on the biological activity of SiO 2 NPs. In vitro studies using various mammalian cells have demonstrated that unmodified SiO 2 NPs exhibit higher cytotoxic and genotoxic properties compared to surface modified NPs. 18, 21, 22 The aim of this study was to investigate the effects of amorphous SiO 2 NPs and their surface modifications in the elicitation phase in a murine model of ovalbuminspecific allergic airway inflammation. SiO 2 and polyethylene gly col (PEG) SiO 2 (SiO 2 PEG) exerted proinflammatory and immunomodulatory activity in allergic airway inflammation, while modifying SiO 2 NPs with amino and phosphate groups markedly decreased these effects. Alternative activation of pulmonary macrophages that take up SiO 2 NPs and distinct chemokine patterns in the lung were identified as underlying mechanisms.
Materials and methods animals
Female 6 to 10weekold BALB/c mice were obtained from Charles River (Wilmington, MA, USA), housed under specific pathogenfree conditions in individually ventilated cages (VentiRack; BioZoneGlobal Ltd, Ramsgate, UK) and fed a standard diet and water ad libitum. The study was conducted under federal guidelines for the use and care of laboratory animals and was approved by the Government of the District of Upper Bavaria and the Animal Care and Use Committee of the Helmholtz Center Munich, Munich, Germany.
NP preparation
Plain SiO 2 (SiO 2 ), PEGylated SiO 2 (SiO 2 PEG), phosphate coated SiO 2 (SiO 2 P), and aminocoated SiO 2 (SiO 2 NH 2 ) NPs were obtained from BASF SE, Ludwigshafen, Germany, and fluorescein isothiocyanate (FITC)conjugated SiO 2 (SiO 2 FITC) NPs from Bayer Technology Services GmbH, Leverkusen, Germany. All NPs were amorphous with a single particle/agglomerate size between 5 and 50 nm, with the exception of SiO 2 FITC (23-30 nm). NPs were freshly diluted in water (aqua ad iniectabilia; B Braun Melsungen AG, Melsungen, Germany) and buffered with phosphatebuffered saline (PBS) to physiological pH, to the final concentration of 1 mg/mL, just before intratracheal instillation. Supernatant controls (SUP) were obtained by hard sedimentation (24,000 rpm, 15 hours). Additional NP characteristics are disclosed in the "Supplementary materials" section.
Study design
To evaluate the immunomodulatory effect of NPs, a protocol of mild allergic inflammation in the lung was used, as previously described ( Figure 1A) . 23 Briefly, mice were sensitized by repetitive intraperitoneal injections of 1 µg ovalbumin (OVA) (grade VI; SigmaAldrich, St Louis, MO, USA) in PBS adsorbed to 2.5 mg aluminum Figure 1 experimental protocol. Notes: (A) BALB/c mice were intraperitoneally sensitized (S) with OVA/aluminum hydroxide or non-sensitized (NS) with phosphate-buffered saline/aluminum hydroxide (black arrows). On day 52, S and NS mice were intratracheally instilled with SiO 2 nanoparticles or with SUP (white arrow) and subsequently challenged with OVA aerosol (arrowhead). Sacrifice was on day 53 or 57, according to the analysis performed (stars). (B) experimental groups. Abbreviations: FITc, fluorescein isothiocyanate; IP, intraperitoneal; IT, intratracheal; OVA, ovalbumin; PEG, polyethylene glycol; SiO 2 , silicon dioxide; siO 2 -Nh 2 , aminocoated siO 2 ; siO 2 -P, phosphate-coated siO 2 ; siO 2 -PEG, PEGylated SiO 2 ; sUP, supernatant controls.
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Surface modifications of silica nanoparticles hydroxide (alum) (Thermo Fisher Scientific, Waltham, MA, USA) on days 0, 7, 14, 28, and 42. Blood samples were taken before and after sensitization. OVA/alumsensitized mice (S mice), compared to nonsensitized mice (NS mice), were characterized by high titers of OVAspecific immuno globulin E (8.05±1.64 versus 0.1±0.03 µg/mL). At day 52, mice were intratracheally instilled with 50 µg (1 mg/mL) of SiO 2 NPs, or with their correspondent SUP ( Figure 1B) . For doseresponse studies, S mice were instilled with 12.5, 25, or 50 µg of SiO 2 and SiO 2 PEG NPs. NP instillation was followed by OVA aerosol challenge for 20 minutes with 1% OVA in PBS delivered by a PARI BOY nebulizer (PARI GmbH, Starnberg, Germany). Lung function, flow cytometry, and confocal analysis were performed on day 53. Bronchoalveolar lavage (BAL), histology, scanning electron microscopy (SEM), and messenger (m)RNA expression anal ysis were performed 5 days after OVA challenge (day 57).
Flow cytometry
On day 53, single cell suspensions were generated from lungs of NS and S mice exposed to SiO 2 FITC or to correspond ing SUP (n=5-7), dissociated with a lung dissociation kit (kit number 130065927; Miltenyi Biotec GmbH, Bergisch Gladbach, Germany), and analyzed by flow cytometry, monitoring the FITC conjugate. Untreated mice were used as negative controls. To investigate the interaction of SiO 2 FITC with different lung cell populations, cells were stained and gated as described previously. 24 antimouse CD45 PE Cyanine7, 7AAD, and antimouse F4/80 PE were obtained from eBioscience (San Diego, CA, USA), antimouse CD11b APCCy™7 from BD Biosciences (San Jose, CA, USA), antimouse CD11c APC from BioLegend (San Diego, CA, USA), and GR1 (LY6C/G) Pacific Orange™ from Invitro gen (Life Technologies, Carlsbad, CA, USA). Samples were measured in a BD FACSCanto II flow cytometer and data were analyzed using a FlowJo graphics application V9.7.2 (TreeStar Inc., Ashland, OR, USA).
Interstitial macrophages were defined as CD45 
Histology and SEM
On day 57, after BAL, the lungs were excised and the left lobe fixed in 4% buffered formalin and embedded in paraffin (n=4-5/group). Sections of 3 µm thickness were stained with hematoxylin and eosin and periodic acid-Schiff. For electron microscopy, lungs were processed as previously described. 25 
Lung function analysis
Lung function analysis was performed on day 53, 24 hours after allergen challenge in intubated, mechanically ventilated ani mals (n=5-8/group; Buxco ® Research Systems, Wilmington, NC, USA). Anesthesia was induced by an intraperitoneal injec tion of ketamine (100 mg/kg) and xylazine (5 mg/kg) in PBS. After cannulation of the trachea, the animals were ventilated with room air at rates of 130 breaths/minute. A protocol for measuring airway hyperreactivity was initiated by challenging the mice with increasing methacholine concentrations by inha lation, using an inline nebulizer (5 µL methacholine solution in PBS delivered for 30 seconds at the following concentrations: 0, 1.25, 2.5, 5, 10, 20, and 40 mg/mL). Data were recorded using FinePoint software version 1.0 (Buxco ® Research Systems). The highest value of respiratory system resistance and the lowest value of dynamic compliance were recorded every 5 seconds during the datarecording interval, which was set at 3 minutes after each methacholine level. The heart rate of each animal was continuously monitored using an elec trocardiography device connected with three subcutaneous electrodes throughout the entire experiment (Buxco ® Research Systems). Table S1 . Data were considered significant with a Pvalue #0.05 with a confidence interval of 95%.
Data analysis
Results are shown as boxplots indicating minimum, 25th percentile, median, 75th percentile, and maximum, or as mean ± standard deviation. Statistical significance among groups was determined by the Mann-Whitney Utest for boxplots, twoway analysis of variance with post hoc least significant difference test for lung function studies, and oneway analysis of variance with Bonferroni post hoc test for PCR and flow cytometry (GraphPad Prism; GraphPad Software, Inc., La Jolla, CA, USA). Statistically significant values were catego rized as follows: P#0.05, P#0.01, and P#0.001.
Results
siO 2 NPs exert proinflammatory and Th2 immunomodulatory activity in vivo
In order to investigate possible proinflammatory and immu nomodulatory effects of SiO 2 , increasing concentrations of SiO 2 NPs (0, 12.5, 25, and 50 µg/mouse) were intratrache ally instilled in the lungs of S mice prior to OVA challenge. Bronchoalveolar lavage fluid (BALF) was analyzed for differential cell count 5 days after OVA challenge. The lowest NP concentration used (12.5 µg) did not evoke a significant increase of inflammatory cells into the BALF compared to the respective SUP. Increasing NP dose to 25 µg led to a significant increase of macrophages (P,0.01) and neutrophils (P,0.01) (Figure 2A ). The highest dose of 50 µg SiO 2 NPs led to a significant increase of macrophages, lymphocytes, neutrophils, and eosinophils (P,0.001) in the BALF compared to sensitized SUP ( Figure 2A ). Similar effects were shown following SiO 2 -PEG instillation ( Figure  S1A ). Intratracheal instillation of 50 µg/mouse SiO 2 NPs in NS mice exerted a proinflammatory effect, leading to sig nificantly increased neutrophils and lymphocytes (P,0.001) and to a slight increase of eosinophils (P,0.05) compared to nonsensitized SUP ( Figure 2B ). These results suggest that SiO 2 NPs exert both a strong proinflammatory and immuno modulatory effect in allergic airway inflammation.
Pulmonary macrophages take up siO 2 NPs
To determine whether OVA sensitization affects pulmonary reten tion of NPs, mice were instilled with SiO 2 FITC or respective SUP prior to OVA challenge. Twentyfour hours later, a minor, but not significant, increase in the percentage of FITC + cells was observed in the lung of S mice, compared to NS mice. FITC + cells in the negative control and in S and NS mice instilled with SUP were not higher than background level ( Figure 3A ).
Flow cytometry of lung cell subtypes showed that macro phages displayed the highest percentage of FITC positivity. In detail, in the lungs of NS mice, 15.3% of alveolar macro phages and 8.2% of interstitial macrophages were positive for SiO 2 FITC NPs. In the lungs of S mice, a significantly increased percentage of alveolar macrophages (23.2%, P,0.01 versus NS mice) and a reduced percentage of interstitial macro phages (4.3%) were positive for SiO 2 FITC ( Figure 3A ). Pulmonary suspensions of negative controls displayed minimal FITC autofluorescence, comparable to the lungs instilled with FITCSUP. A minimal percentage of Tcells and neutrophils were FITC positive (data not shown).
To evaluate whether SiO 2 NPs interacted only with the surface of macrophages or were internalized by these cells, confocal analysis was performed 24 hours after OVA challenge. Figure 3B shows representative lung sections of NS and S mice stained with the macrophage marker CD68 (red), and with DAPI for the nuclei (blue), suggesting that pulmonary macrophages take up SiO 2 NPs (green) in both NS and S mice. The 100× orthogonal sections of single cells show that NPs were present inside the macrophages.
Specific surface modifications of siO 2 NPs significantly reduce their immunomodulatory activity functionalization of SiO 2 NPs, we evaluated the BAL cell infiltration in NS and S mice after intratracheal instilla tion of SiO 2 NPs with PEG, amino, and phosphate surface modifications.
Similarly to SiO 2 plain NPs, SiO 2 PEG NPs exerted proinflammatory effects, with a significant increase of neu trophils and lymphocytes (P,0.001) and a minor increase of eosinophils (P,0.05), in NS mice. Moreover, functionalizing SiO 2 plain NPs with PEG did not impair the immunomodula tory effect of SiO 2 NPs in the BALF of S mice. Lymphocyte, neutrophil, and eosinophil total cell numbers were still significantly increased in the BALF of S mice (P,0.001) ( Figure 4A ).
In contrast, mice treated with SiO 2 P or SiO 2 NH 2 (Figure 4B and C) showed minimal proinflammatory effects in NS mice, which reached significance only for neutrophil and eosinophil counts in SiO 2 NH 2 treated mice (P,0.05). In S mice, no sig nificant effects on the BALF total cell count were shown com pared to control, apart from a slight increase in the macrophage cell number after SiO 2 NH 2 instillation (P,0.05). siO 2 and siO 2 -PEG increase pulmonary inflammation and goblet cell necrosis
To further elucidate the effects of SiO 2 NPs and their surface coatings, we evaluated pulmonary inflammation in the lung. Intratracheal instillation of the supernatants of all four NP preparations did not affect pulmonary histopathology ( Figure  5A ). In S mice, SiO 2 and SiO 2 PEG NPs increased the inflam matory lung infiltrate and, although in higher degree SiO 2 PEG, mucus hypersecretion when compared to sensitized SUP mice ( Figure 5A ). In contrast, mice treated with SiO 2 P and SiO 2 NH 2 NPs showed minimal pulmonary inflammation when compared with sensitized SUP mice; these observations were in accordance with the effects observed in the BALF differential cell count in S mice. Irrespective of functional ization, SiO 2 NPs did not induce pulmonary pathological alterations in NS mice (data not shown). To evaluate structural changes of the airways follow ing SiO 2 NP instillation, SEM was performed. NS mice instilled with the four different particles and respec tive supernatants showed no significant ultrastructural modifications of the lung (data not shown), apart from sporadic hypotrophy of Clara cells present in all samples ( Figure 5B ). S mice instilled with the four different sensi tized SUP developed the classical pulmonary alterations due to OVA sensitization and challenge, ie, metaplasia of Clara cells to mucussecreting goblet cells ( Figure 5B ). Lungs of S mice instilled with SiO 2 and SiO 2 PEG NPs showed morphological alterations of goblet cells, includ ing the perforation of cell membrane, indicating cell death ( Figure 5B ). In contrast, no additional effects due to particle exposure were observed in S mice instilled with SiO 2 NH 2 or SiO 2 P ( Figure 5B ). siO 2 and siO 2 -Peg NPs, but not siO 2 -P and siO 2 -Nh 2 NPs, induce moderate alterations in lung function
Lung function tests performed 24 hours after intratracheal instillation of SiO 2 NPs and OVA challenge in S mice showed different results for the four particles tested. SiO 2 plain did not have an effect on respiratory system resis tance when compared to SUP; however, dynamic compli ance was significantly decreased in S mice instilled with SiO 2 already, before methacholine challenge (P,0.05), maintaining the lower trend at 1.25 and 2.5 mg mL Figure 6A and B). The instillation of SiO 2 PEG in S mice led to an increase of resistance following the highest methacholine concentration, namely 40 mg/mL (P,0.01). Dynamic compliance was lower in SiO 2 PEG with respect to sensitized SUP, but this difference was not statistically significant ( Figure 6A and B) . On the contrary, SiO 2 P and SiO 2 NH 2 NPs had no effect on either lung resistance or compliance in S mice ( Figure 6 A and B) . The effect of the instillation of NPs in NS mice was minimal for all NPs tested ( Figure 6 ). ) and eosinophil (Ear11) activation, and had no effect on the markers for classical activation (CxCL9, Nos2) ( Figure 7 and Figure S2 ). These effects of NPs were observed also for other chemotactic chemokines (MIP-3/ CCL20, MDC/CCL22, MIP-2/CxCL2) as well as for asthma markers (Retnlg, Chi3l4). Muc5ac was only upregulated by SiO 2 PEG in S mice ( Figure S2 ). The effects of SiO 2 and SiO 2 PEG NP instillation on selective Th2 gene expression levels were dose dependent, and significant upregulation of 
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IL-13, MIP-1/CCL3
, and Arg1 was detected at the highest concentration (50 µg/mouse) ( Figure S1B ).
Discussion
In this study, we used a wellcharacterized, murine model of mild allergic airway inflammation 23 Only a few studies have investigated the modulation of allergic disease by NPs. 19, 20, 26 Our results showed sig nificant immunomodulatory effects exerted by SiO 2 NPs in OVAsensitized mice, with a significant increase in BALF inflammatory infiltrate, mainly comprising macrophages and eosinophils. Our data are in line with a previous study testing titanium dioxide and gold NPs in the elicitation phase of the allergic response. 26 We focused our readout to day 5 after challenge. The reason for this choice was that this time point is representative for the elicitation phase of the aller gic response in our mouse model, since it is characterized by strong recruitment of inflammatory cells into the lung. 27 Since the Th2adjuvant effects of SiO 2 NPs applied during the sensitization phase have been previously demonstrated, 19, 20 we now can assume that SiO 2 NPs also exacerbate the elicitation phase of allergic airway inflammation. SiO 2 NPs showed a strong proinflammatory effect in NS mice, leading to neutrophil and lymphocyte recruitment after intratracheal instillation, which is in agreement with a previous work 16 showing neutrophil recruitment in the early inflammation stages (up to 1 week after instillation) following intratracheal instillation of SiO 2 NPs. We also demonstrated an increase of eosinophils in NS mice exposed to SiO 2 NPs, a phenomenon also observed in rats after titanium NP exposure. 10 The observation that, 24 hours after intratracheal instil lation, the percentage of FITC + cells in S mice was higher compared to NS mice, is in agreement with our earlier study. 28 NP uptake occurred mainly by pulmonary macrophages, as has been observed in healthy animals. 29 Confocal analysis 
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Surface modifications of silica nanoparticles confirmed that NPs were located inside the phagocytes, and did not just interact with the cell surface. Moreover, we demonstrated that, in S mice, more alveolar macrophages phagocytize NPs compared to in NS mice and, consequently, particle translocation and retention in the interstitium by interstitial macrophages occurs to a higher extent in NS mice. Since these cells exert immunoregulatory properties, this could explain the shortterm NPinduced inflamma tion in NS mice. 16 The higher percentage of phagocytizing alveolar macrophages in S mice relates to our observation of SiO 2 dependent enhancement of expression of markers for alternatively activated macrophages, like arginase 1 and mannose receptors in NPtreated S mice. These cells show increased phagocytic activity 30 and aggravate allergic airway inflammation. 31 The SiO 2 dependent increase in alternatively activated macrophages is of high clinical importance and could account, at least in part, for the differential localization of SiO 2 NPs in S and NS mice.
A few groups have investigated the effects of surface modi fications of SiO 2 NPs in vitro and in vivo; 21, 22, 32, 33 however, to our knowledge, this is the first study that explores the effect of SiO 2 NP functionalization on their proinflammatory and immunomodulatory effects in allergic airway inflammation in vivo. Our data showed that coating NPs with shortchain PEG was not a successful strategy for modifying biological properties of SiO 2 NPs: in fact, both NS and S mice treated with SiO 2 PEG responded similarly in terms of inflammation to those treated with SiO 2 plain. Moreover, both SiO 2 plain and SiO 2 PEG enhanced mucus production and exerted cytotoxic effects. The ultrastructural damages are very likely mediated by SiO 2 NPinduced oxidative stress and apoptosis. 34 Possibly, the 500 Da PEG chain used to coat the NPs was not long enough to mask the surface of the NPs. Lipka et al suggested that the PEG chain length is essential for determining the biodistribution of NPs. 11 Moreover, both molecular weight and chain density of PEG influence mesoporous SiO 2 NP binding to serum proteins and phagocytosis from THP1 macrophages, proposing 10 kDa as the minimal molecular weight to inhibit phagocytosis. 35 In light of these studies, our PEG chain might have been too small to mask the effect of SiO 2 NPs. In contrast, our results showed that coating with amino or phosphate groups success fully mitigated the toxic and immunomodulatory effects of SiO 2 NPs. These effects were observed at histopathological and functional levels, with less BALF cell infiltrate, absence of goblet cell necrosis, and normal lung function in both NS and S mice instilled with SiO 2 P and SiO 2 NH 2 versus SiO 2 plain or SiO 2 PEG. It has been demonstrated that coating of NPs can affect their interaction with biological fluids. 36 Proteins bind to the surface of NPs and form a coating known as the "protein corona," which can critically affect the interaction of the NPs with living systems. Speculation can be made as to whether our surface modifications of SiO 2 NPs affected the thermodynamic characteristics of lipid monolayers, including lung surfactant or cell membrane, as previously observed in 1,2dipalmitoylsnglycerol3phosphocholine-cholesterol Langmuir monolayers. 37, 38 Different cellular uptake mechanisms may be involved when NPs are functionalized; in fact, it has been previously shown that SiO 2 NPs coated with amine or carboxyl groups display a different intracellular distribution compared to those that are uncoated. 39 In our model, both amino and phosphate functionalization failed to regulate markers of macrophage activation, suggesting a different compartmentalization of SiO 2 P and SiO 2 NH 2 within macrophages. Further studies should investigate these aspects.
The successful mitigation of effects of SiO 2 NPs coated with amino groups is in agreement with the results of Yamashita et al, 32 which showed less fetotoxicity of amino coated NPs when compared to plain NPs. To the best of our knowledge, this is the first study showing mitigation of side effects of SiO 2 NPs after phosphate coating.
Our findings on the expression of key genes of inflam mation support the hypothesis that functionalization of NPs modify their biological activity in vivo. The immu nomodulatory NPs (SiO 2 plain and SiO 2 PEG), but not the counterpart NPs (SiO 2 P and SiO 2 NH 2 ), increased the inflammatory milieu in the pulmonary tissue, with upregulation of Th2 cytokines, as well as sensitization induced chemokines, the latter responsible for chemoat traction of granulocytes (MIP-1/CCL3 and MIP-2/CxCL2, KC/CXCL1), lymphocytes (Tarc/CCL17, MIP-3/CCL20, and MDC/CCL22), and macrophages (MCP-1/CCL2). 40 These data support the concept of recruitment of inflam matory cells observed in the BALF of OVAsensitized mice by immunomodulatory NPs only. Furthermore, our gene expression analysis showed that only SiO 2 plain and SiO 2 PEG NPs could lead to increased marker of eosinophils acti vation (Ear11) 41 and alternative activation of macrophages, with no modulation of markers of classical activation of macrophages (Arg1/Retnla versus Nos2/CxCL9). 31 The asthmatic profile present in the lungs of S mice was further confirmed by the upregulation of genes involved in allergic airway inflammation: Chitinase 3like 4 (Chi3l4) 42 was modulated in our experiments by both SiO 2 and SiO 2 PEG NPs in S mice. Among the resistin family, FIZZ1 (Retnla) and FIZZ2 (Retnlb), but not FIZZ3 (Retnlg), mRNAs were
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Marzaioli et al found to be upregulated in the lungs of S mice 6 hours after the OVA challenge: 43 in this study we still found modulation of FIZZ1 and FIZZ3 in S mice 5 days after OVA challenge, which was significantly enhanced by both SiO 2 and SiO 2 PEG NPs and downregulated by SiO 2 NH 2 . The prolongation of FIZZ1 and FIZZ3 expression after challenge may have been due to our relatively long sensitization protocol.
In most of the genes evaluated in our array, SiO 2 PEG had a greater effect than SiO 2 . A clear example regards the regulation of the mucin Muc5ac gene, responsible for mucus production, 44 which was selectively upregulated by SiO 2 PEG NPs but not by SiO 2 NPs. Since IL-13 is a known modulator of Muc5ac, 45 the lower expression of IL-13 mRNA upon SiO 2 compared to SiO 2 PEG could explain this finding.
Conclusion
Our observations indicate the need for selecting surface modi fications of engineered NPs for commercial purposes, in order to improve their biological activity and reduce or abolish their side effects. Moreover, our results can inform and help in the choice of drug delivery strategy, as the selection of the surface modification of NPs is crucial for targeted application. 
Supplementary materials Nanoparticle characteristics
Covalent functionalization of nanoparticles (NPs) was obtained with three different lowmolarmass silanes:
• PEGylated silicon dioxide (silica [SiO 2 ]) NPs: polyethylene glycol of chain length molecular weight =500 g/mol.
• Aminocoated SiO 2 NPs: carry a positively charged amino end group on a flexible, but short C3 linker.
• Phosphatecoated SiO 2 NPs: carries a negatively charged PO 3 end group on the same C3 linker. Successful functionalization was confirmed by trans mission electron microscopy, which showed that NPs maintained a spherical structure with no aggregates, agglomerates, or secondary nucleation. Size distribution in water as measured by analytical ultracentrifugation 1 was not significantly changed by the surface modification, with a peak diameter at 14 nm as shown in Figure S3A . Surface charge was measured by electrophoretic mobility with pH titration (Figure S3B) of free SiOx groups and free functionalized groups, under lining a partial coverage of the NPs ( Figure S3C shows an example of one of the NPs used in this study, phosphate coated SiO 2 NPs). All NPs used in this study were tested for lipopolysaccharide concentration. This was ,0.25 EU/ mL NPs suspension, which resulted in ,0.000055 EU/ intratracheal instillation for the highest NP concentrations as determined by limulus amebocyte lysate assay (PyroGene rFC Endotoxin Detection system, product number 50658U; Lonza Group Ltd, Basel, Switzerland). Supernatants for each NP were obtained by hard sedi mentation (24,000 rpm, 15 hours), with successful removal 
Mass distribution dc/dD
Diameter/nm of 95%-98% of NPs in solution. Table S2 summarizes the characteristics of the NPs.
SiO 2 FITC NPs were prepared as described previously. 2 The FITC was covalently bound to the SiO 2 core and an SiO 2 shell was then produced with the addition of tetraethox ysilane. This shell prevented the influence of the FITC dye on the charge of the NP cores. Successful synthesis of the fluorescent SiO 2 NPs (SiO 2 FITC) was confirmed by trans mission electron microscopy, which showed spherical NPs with no aggregates, agglomerates, or secondary nucleation. The size of the particles was determined by transmission electron microscopy and dynamic light scattering ( Figure  S4A : plain SiO 2 ; B: SiO 2 FITC). The surface charge was measured by electrophoretic mobility with pH titration. The results showed no significant difference between the plain SiO 2 and the fluorescent SiO 2 NPs. The fluorescent properties were confirmed by fluorescence spectroscopy ( Figure S5 ). Figure S5 shows the absorption and the emission spectra of the SiO 2 particles excited at 460 nm.
